r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with Amyloid Deposits in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cookson, L; Lukas, MA; Millns, H; Richards, D | 1 |
Pepys, MB; Pepys-Vered, ME | 1 |
1 trial(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloid Deposits
Article | Year |
---|---|
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
Topics: Amyloidosis; Carboxylic Acids; Follow-Up Studies; Humans; Plaque, Amyloid; Pyrrolidines; Serum Amyloid P-Component | 2022 |
1 other study(ies) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloid Deposits
Article | Year |
---|---|
Targeted treatment for amyloidosis.
Topics: Amyloid; Amyloidosis; Carboxylic Acids; Disease Management; Genetic Therapy; Humans; Molecular Targeted Therapy; Plaque, Amyloid; Prealbumin; Protein Stability; Pyrrolidines; Sequestering Agents; Serum Amyloid A Protein; Serum Amyloid P-Component | 2014 |